Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Shalina Laboratories Private Limited, is an unlisted private company incorporated on 31 August, 2020. It is classified as a private subsidiary of a foreign company and is located in , Maharashtra. It's authorized share capital is INR 320.00 cr and the total paid-up capital is INR 82.76 cr.
Shalina Laboratories's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2025. It's EBITDA has increased by 7.73% over the previous year. At the same time, it's book networth has increased by 7.57%.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Nominee Director | Sundar Sankaran | 01098634 | 5 years |
| Director | Fazle Abbas Virji | 07085209 | 5 years |
| Director | Shalina Clifford | 07085210 | 5 years |
| Additional Director | Prasad Shyamsunder Deshpande | 10489379 | 2 years |
| Company Secretary | Sushil Kumar Agarwal | <HIDDEN> | 2 years |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2025 available in Tofler Pro
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ICICI Bank Limited
No. of Loans: 1
Total Amount : 35.0 cr
Bank of India
No. of Loans: 1
Total Amount : 18.0 cr
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| ADVANTAGE-INDIA CONSULTING PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| FINBERRY ACADEMY PRIVATE LIMITED |
Strike Off
|
10.0 L | 1 | Maharashtra |
| NJ TRUSTEE PRIVATE LIMITED |
Active
|
10.0 L | 1 | Maharashtra |
| SHALINA TRADING CO PVT LTD |
Active
|
1.0 L | 2 | Maharashtra |
| SHALINA LABORATORIES PRIVATE LIMITED |
Amalgamated
|
8.4 Cr | 4 | Maharashtra |
| SHALINA PHARMACEUTICALS PRIVATE LIMITED |
Active
|
25,000.0 | 4 | Maharashtra |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| SHALINA PHARMACEUTICALS PRIVATE LIMITED | Maharashtra | 2021 | ₹ 25,000.0 |
Read more
The incorporation date of SHALINA LABORATORIES PRIVATE LIMITED is 31 August, 2020
The authorized share capital of SHALINA LABORATORIES PRIVATE LIMITED is INR ₹ 320.0 Cr.
The paid-up capital of SHALINA LABORATORIES PRIVATE LIMITED is INR ₹ 82.8 Cr.
The registered address of SHALINA LABORATORIES PRIVATE LIMITED is 96 MAKER CHAMBER VI NARIMAN POINT, Mumbai City, MUMBAI, Maharashtra, India, 400021 - 400021
The CIN number of SHALINA LABORATORIES PRIVATE LIMITED is U33100MH2020FTC344984.